ArticleJournal of gastrointestinal oncology2025

Efficacy and safety of camrelizumab in combination with S-1 plus oxaliplatin sequenced by camrelizumab-based maintenance therapy as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma: a retrospective cohort study.

Wan-Ren Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.